Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Enwave: More Than Cheesy Treats

|Includes: EnWave Corp. (NWVCF)

It is always fun due diligence for companies with food products. Consideration of EnWave Corporation (OTCPK:NWVCF) requires a trip to Starbucks for 'Moon Cheese' - a crunchy, cheese treat made with EnWave's proprietary knowhow. So head to the first Starbucks you can find and grab a bag to eat while reading the rest of this post.

Moon Cheese is produced with 'radiant energy vacuum' technology that delivers efficient dehydration for food at low temperatures. The technology involves combination of microwave technologies and the right vacuum and is harness in modular equipment especially designed for scalability. EnWave calls its technology REV and has a string of patents to protect their processes and designs from jealous competitors.

Moon Cheese is only one of many applications for EnWave's equipment. The tasty snack is produced and marketed by NutraDried LLP, in which EnWave is a significant investor. Management is not looking to go into the snack business. However, the all-natural snack with long-shelf life even with no preservatives provides management with a compelling 'show-and-tell' prop for sales calls as well as investor presentations. I recommend the jalapeno and cheddar!

EnWave has chosen to license its dehydration technology into eight different markets, such as snacks, food ingredients, biochemicals and other pharmaceuticals. Indeed, the company has already signed over a dozen license agreements that will bring in streams of upfront fees and royalty streams based on subsequent production. The company has developed three different platforms with REV at the core: nutraREV to dry food products, powderREV for bulk dehydration of food cultures and biochemicals, and quantaREV for dehydrating biopharmaceuticals like vaccines.

In the last two months alone, EnWave has signed a half-dozen new license agreements and expanded other relationships.

The most recent licensee is perhaps the highest profile customer EnWave has landed yet. Perdue Farms has been granted exclusive use of REV dehydration technology to process pet food and treats in the U.S. and Canada. Known for its chilled chicken and turkey meat products, Perdue will first use a small REV unit for product development and marketing trials. The agreement commits Perdue to purchase a larger scale machine for volume production. Under the agreement EnWave receives a deposit and additional royalty payments based on Perdue's pet food sales.

Perdue's bold move might have been triggered by an earlier announcement from EnWave that another unnamed meat processor based in Australia or New Zealand had signed a license option. EnWave is renting an REV unit to this potential licensee for research and development purposes. At the time of the announcement, EnWave laid claim to discussions with another six meat processors in Europe and the Americas. Likely Perdue was one of them.

Recently Milne Fruit Products ordered an additional 120 kilowatt REV machine to expand production of its 'Microdried' line of fruits and vegetables. The expanded license now includes apples, grapes, kale, green beans, squash among a number of other popular fruits and vegetables. EnWave is apparently receiving quarterly royalty payments from Milne, which will increase beginning in second quarter 2017 when the new microdried products begin shipping to customers.

Other new licensee is Kesito LLC, a producer of healthy snacks based in Greece. Kesito has licensed REV for production of dried cheese snacks. Merom Farms Ltd. will be using small 20 kilowatt machine with REV technology to produce a wasabi product. Wasabi is also called Japanese horseradish that is served as a condiment and is popular for its pungent aroma and spicy flavor.

Although EnWave has had a string of impressive new and expanded license announcements in recent months, its successes will take time to translate into revenue and earnings. Upfront fees help defray the costs of putting new contracts in place but not much more. Yet if REV licensees meet with commercial success, EnWave could be the recipient of building royalties in the coming years.

Consequently, EnWave is not yet profitable. In the nine months ending June 2016, the company reported $9.4 million in total revenue largely from royalties. The reported net loss was $209,000 or $0.01 per share. This compares quite favorably with the same nine months in the previous year when the net loss was $5.4 million on $3.0 million in total revenue.

The company had to use $1.8 million of its cash resources to support operations in the first nine months of 2015, but in the most recently nine months ending June 2016, operations actually generated a modest sum of $81,320. It is not clear that the company has achieved the scale that can consistently generate positive cash flows. However, reliance on cash in the bank has been reduced and operations are in a better position to create value rather than relying on new capital investment.

The company has a relatively strong balance sheet to support its business development efforts. Cash totaled $4.4 million at the end of June 2016, and there is no long-term debt. Based on recent performance, EnWave could survive for some time without new capital. However, investors should expect an increase in spending in the near-term that could use of cash resources at a faster pace. The company must deliver new equipment to make good on those new and expanded license agreements. Also market penetration efforts come with a price tag for marketing and sales personnel, trade show participation and other travel to bring Enwave's message to potential customers.

Priced below one U.S. dollar per share and trading in low volumes with a wide bid-ask spread, EnWave shares may not be appealing for risk adverse investors. However, even the most cautious investor would have to admit that Moon Cheese is a unique and tasty treat that can only be made with EnWave's technology. A packet of Moon Cheese is priced at $4.95 at a Starbuck's counter. The question for investors to deliberate is whether EnWave can capture its fair share of the value in the products made with its REV technology. Enwave management wants that fair share to be delivered to the company through royalties. In the coming months investors will learn more about Enwave's new relationships and the royalties they can generate. It will be an interesting comparison between that royalty value and the current stock share price.

Neither the author of the Small Cap Strategist web log, Crystal Equity Research nor its affiliates have a beneficial interest in the companies mentioned herein.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.